Literature DB >> 7743576

Calcium channel blockade and uncontrolled blood pressure during phaeochromocytoma surgery.

J Munro1, B J Hurlbert, G E Hill.   

Abstract

Phaeochromocytoma has traditionally been managed by preoperative adrenergic blockade followed by surgical devascularization and excision. Recently, various studies have reported the use of calcium channel blocking drug therapy, either as monotherapy or in combination with other non-adrenergic blocking antihypertensive medications for blood pressure control in the preoperative management of phaeochromocytoma. In this case report, diltiazem as monotherapy was used to establish adequate preoperative blood pressure control in a patient with metastatic phaeochromocytoma to the liver. During cryoablation therapy surgery of the liver metastasis, the patient demonstrated extreme blood pressure lability requiring nitroprusside and high end tidal concentrations of isoflurane for blood pressure control. This case report suggests that during resection of a phaeochromocytoma where tumour devascularization is not obtainable, calcium channel blocking drugs as monotherapy may be inadequate to control blood pressure extremes. The authors suggest that under clinical circumstances reported above strong consideration be given to the use of standard adrenergic blocking drug therapy pre- and intraoperatively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7743576     DOI: 10.1007/BF03010683

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  15 in total

Review 1.  Management of pheochromocytoma.

Authors:  B Shapiro; L M Fig
Journal:  Endocrinol Metab Clin North Am       Date:  1989-06       Impact factor: 4.741

Review 2.  Anaesthesia for phaeochromocytoma.

Authors:  J Pullerits; S Ein; J W Balfe
Journal:  Can J Anaesth       Date:  1988-09       Impact factor: 5.063

3.  Effectiveness of long-acting nifedipine in pheochromocytoma.

Authors:  S Takahashi; T Nakai; R Fujiwara; Y Kutsumi; T Tamai; S Miyabo
Journal:  Jpn Heart J       Date:  1989-09

4.  Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients.

Authors:  C Proye; D Thevenin; P Cecat; P Petillot; B Carnaille; P Verin; M Sautier; N Racadot
Journal:  Surgery       Date:  1989-12       Impact factor: 3.982

5.  [Pre- and postoperative antihypertensive treatment with calcium antagonist in pheochromocytoma].

Authors:  P Colson; J Ribstein; P A Chaptal; A Mimran; B Roquefeuil
Journal:  Arch Mal Coeur Vaiss       Date:  1990-07

6.  Use of diltiazem to control circulatory fluctuations during resection of a phaeochromocytoma.

Authors:  H Tokioka; T Takahashi; Y Kosogabe; Y Ohta; F Kosaka
Journal:  Br J Anaesth       Date:  1988-04       Impact factor: 9.166

7.  Nifedipine and surgical removal of phaeochromocytoma.

Authors:  P Chari; R N Katariya; R K Venkataraman; A Trikha
Journal:  Anaesthesia       Date:  1988-09       Impact factor: 6.955

8.  The different effects of D-600 (methoxyverapamil) on the release of adrenal catecholamines induced by acetylcholine, high potassium or sodium deprivation.

Authors:  J E Pinto; J M Trifaró
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739

9.  Phaeochromocytoma and hypertrophic cardiomyopathy: apparent suppression of symptoms and noradrenaline secretion by calcium-channel blockade.

Authors:  D Serfas; D M Shoback; B H Lorell
Journal:  Lancet       Date:  1983-09-24       Impact factor: 79.321

10.  Prazosin in the diagnosis and treatment of pheochromocytoma.

Authors:  J M Wallace; D P Gill
Journal:  JAMA       Date:  1978-12-15       Impact factor: 56.272

View more
  2 in total

Review 1.  Pheochromocytoma as an endocrine emergency.

Authors:  Frederieke M Brouwers; Jacques W M Lenders; Graeme Eisenhofer; Karel Pacak
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Phaeochromocytoma and calcium channel block.

Authors:  J D Tobias
Journal:  Can J Anaesth       Date:  1995-09       Impact factor: 5.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.